<p>The expression of CD86 (A), CD83 (B), HLA-DR (C) was analyzed by flow cytometry on non-irradiated (- UVA) or irradiated (1 J/cm<sup>2</sup> UVA with 3.4 mW/cm<sup>2</sup>) PBMDCs. Box plots indicate median (horizontal line), 1<sup>st</sup>, 3<sup>rd</sup> quartile (box) and maxima/minima-values (T-bars) of at least 40 independent donors. MFI: Mean fluorescence intensity.</p
PBMCs were stimulated with anti-CD3 mAb (OKT3) in the presence or absence of CD99HIgG or HIgG contro...
Representative flow cytometry profile and cumulative data of cells that were mock-treated (red), cha...
<p>DCs were treated with NSRmock, NSR, LPS, LPS+NSRmock or LPS+NSR and were harvested at 0, 4, 8,12,...
<p>Cells were exposed to the indicated UVA doses (X axis) with intensities of 1.7 mW/cm<sup>2</sup> ...
<p>Histogram overlays show CD83 (A), HLA-DR (B) and CD86 expression (C) measured by flow cytometry o...
<p>PBMDCs were incubated with the indicated (X axis) concentrations of photoallergens and allergens ...
<p>(A) Phenotypic changes in expression of CD40, CD80 and CD86 maturation markers in TCL-loaded DCs ...
<p>Representative FACS analyses (FACS Diva software, FACS Aria II, BD, CA) of MSCs at passage 3 were...
<p>T cells from seven donors were transfected with the vectors Scr-Vec-GFP(−) (black bars) or Scr-Ve...
<p>The iDCs were treated with mock, BCG-CS-NPs, UVI-DENV (1, 3 and 10 μg) and DNV (1, 3 and 10 μg) f...
For an allogeneic MLR, responder cells from 6 healthy donors were stained with CFSE and mixed with γ...
<p>PBMC from LTBI+ donors were stimulated with PPD or left unstimulated, stained with antibodies aga...
Flow-cytometry analysis of healthy donor and patients PBMC following three days of PMA/ionomycin sti...
<p>Histograms showing the expression of CD25, CD69, CD38 and HLA-DR from gated CD3+CD4+ cell populat...
Ctively. The expression of CD80, CD83, CD86 and HLA-DR was analyzed on fixed cells by FACScalibur fl...
PBMCs were stimulated with anti-CD3 mAb (OKT3) in the presence or absence of CD99HIgG or HIgG contro...
Representative flow cytometry profile and cumulative data of cells that were mock-treated (red), cha...
<p>DCs were treated with NSRmock, NSR, LPS, LPS+NSRmock or LPS+NSR and were harvested at 0, 4, 8,12,...
<p>Cells were exposed to the indicated UVA doses (X axis) with intensities of 1.7 mW/cm<sup>2</sup> ...
<p>Histogram overlays show CD83 (A), HLA-DR (B) and CD86 expression (C) measured by flow cytometry o...
<p>PBMDCs were incubated with the indicated (X axis) concentrations of photoallergens and allergens ...
<p>(A) Phenotypic changes in expression of CD40, CD80 and CD86 maturation markers in TCL-loaded DCs ...
<p>Representative FACS analyses (FACS Diva software, FACS Aria II, BD, CA) of MSCs at passage 3 were...
<p>T cells from seven donors were transfected with the vectors Scr-Vec-GFP(−) (black bars) or Scr-Ve...
<p>The iDCs were treated with mock, BCG-CS-NPs, UVI-DENV (1, 3 and 10 μg) and DNV (1, 3 and 10 μg) f...
For an allogeneic MLR, responder cells from 6 healthy donors were stained with CFSE and mixed with γ...
<p>PBMC from LTBI+ donors were stimulated with PPD or left unstimulated, stained with antibodies aga...
Flow-cytometry analysis of healthy donor and patients PBMC following three days of PMA/ionomycin sti...
<p>Histograms showing the expression of CD25, CD69, CD38 and HLA-DR from gated CD3+CD4+ cell populat...
Ctively. The expression of CD80, CD83, CD86 and HLA-DR was analyzed on fixed cells by FACScalibur fl...
PBMCs were stimulated with anti-CD3 mAb (OKT3) in the presence or absence of CD99HIgG or HIgG contro...
Representative flow cytometry profile and cumulative data of cells that were mock-treated (red), cha...
<p>DCs were treated with NSRmock, NSR, LPS, LPS+NSRmock or LPS+NSR and were harvested at 0, 4, 8,12,...